Company: ACTG
Filing Date: 2025-03-17
Form Type: 10-K
Source: 0000934549-25-000004
Chunk: 19

Company: ACACIA RESEARCH CORP
Filing Date: 2025-03-17
Form: 10-K
Item: Item 8
Chunk 19
---
— — (142,759)— — (614)— — (614)Compensation expense for   share-based awards— — — — — 3,297 — — 3,297 Acquisition of Benchmark— — — — — — — 9,821 9,821 Balance at December 31, 2023— $— 99,895,473 $100 $(98,258)$906,153 $(239,729)$21,343 $589,609 

The accompanying notes are an integral part of these consolidated financial statements.

F-5

ACACIA RESEARCH CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

Years Ended December 31,20242023Cash flows from operating activities:Net (loss) income including noncontrolling interests in subsidiaries$(34,698)$68,930 Adjustments to reconcile net (loss) income including noncontrolling interests in subsidiaries to net cash provided by (used in)   operating activities:Depreciation, depletion and amortization33,574 14,728 Accretion of asset retirement obligation986 — Change in fair value of Series A redeemable convertible preferred stock embedded derivatives— (3,954)Change in fair value of Series B warrants— (2,762)Gain on exercise of Series B warrants— (1,525)Compensation expense for share-based awards4,795 3,297 Loss (gain) on foreign currency exchange370 (53)Change in fair value of equity securities31,412 (31,423)(Gain) loss on sale of equity securities(28,861)10,930 Earnings on equity investment in joint venture— (4,167)Unrealized loss (gain) on derivatives610 (781)Deferred income taxes, net of acquired net deferred tax assets(6,051)(3,657)Changes in assets and liabilities:Accounts receivable69,225 (70,313)Inventories1,054 3,301 Prepaid expenses and other assets(9,329)(820)Accounts payable and accrued expenses(8,124)(4,651)Royalties and contingent legal fees payable(5,338)751 Deferred revenue497 (337)Net cash provided by (used in) operating activities50,122 (22,